Observational Study Guidance Needed For CER – Vanderbilt’s Harrell
Executive Summary
With members of the Patient-Centered Outcomes Research Institute’s Methodology Committee expected to be named by early in 2011, one area where they could start to improve comparative effectiveness research is in providing solid guidance for conducting observational studies.
You may also be interested in...
PCORI Should Take Lead On Public CER Inventory, Pharma Groups Tell HHS
Development of a publicly available repository of comparative effectiveness research should grow out of the work of the soon-to-be established Patient Centered Outcomes Research Institute, groups representing pharmaceutical industry interests urged in recent comments to HHS
CER Policy Does Not Equate To Head-To-Head Trials, UBC's Luce Says
While there are many fears that comparative effectiveness research will be used to pick winners and losers when products are pitted against one another, United BioSource Corp.'s Bryan Luce does not see head-to-head trials becoming the primary focus of CER activity in the U.S., at least on the federal level
WellPoint's CER Guide Describes How It Will Determine Usefulness Of Studies
WellPoint has released guidelines for the submission and evaluation of comparative effectiveness research that it will use in reviewing drugs for its formulary